The dynamic nature of start-ups and a desire to explore India’s “start-up boom” attracted Revanth to the early-stage Venture Capital industry. At Endiya, Revanth is involved in both Healthcare and Technology domains through scouting new investments, due diligence followed by associated transactions as well as documentation process, and portfolio management.
Prior to joining Endiya, Revanth worked as an equity analyst at J.P. Morgan, where he was a part of the sell-side research team that covered small and mid-cap Biotechnology stocks. During his tenure, he evaluated multiple Biotech companies and in turn, helped in the formulation of investment recommendations for the clients. He started off his career with a brief stint at UBS Verity where he assisted UBS Healthcare Investment Bankers on pre/post-mandate operations for M&A and public offerings.
Revanth holds a Bachelor’s degree in Biotechnology from Indian Institute of Technology Madras.